- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01152411
Safety and Efficacy of Autologous Bone Marrow Stem Cells for Treating Chronic Renal Failure
Use of Autologous Bone Marrow Stem Cell Transplantation in the Treatment of Chronic Renal Failure in 5 Indian Patients - ABMST-CRF Study (Autologous Bone Marrow Stem Cell Transplantation-CRF)
Chronic renal failure (CRF, or "chronic kidney failure", CKF, or "chronic kidney disease", CKD) is a slowly progressive loss of renal function over a period of months or years and defined as an abnormally low glomerular filtration rate, which is usually determined indirectly by the creatinine level in blood serum.
CRF that leads to severe illness and requires some form of renal replacement therapy(such as dialysis) is called end-stage renal disease (ESRD). While renal replacement therapies can maintain patients indefinitely and prolong life, the quality of life is severely affected. Renal transplantation increases the survival of patients with stage 5 CKD significantly when compared to other therapeutic options; however, it is associated with an increased short-term mortality (due to complications of the surgery).
In view of the above, there is definitely an urgent need for finding different methods of treatment for these patients who cannot undergo established modalities of treatment or these have been tried unsuccessfully hence the inadequacy of current treatment modalities and insufficiency of donor organs for transplantation have driven a search for improved methods of dealing with renal failure. The rising concept of cell-based therapeutics has provided a framework around which new approaches are being generated, and its combination with advances in stem cell research stands to bring both fields to clinical fruition. Since CRF affects a large number of these patients who will lose their productive life, stem cell implantation can offer some promise of improved health.
In our present study, we want to evaluate the safety and efficacy (to know / observe for Proof of concept in five indian patients) if any, of autologous bone marrow derived stem cells injected into the Renal Artery in five (initially five patients, can be increased to ten patients after observing the initial results) patients with Chronic Renal Failure.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Phase 2
- Phase 1
Contacts and Locations
Study Locations
-
-
Karnataka
-
Bengaluru, Karnataka, India, 560010
- St. Theresa's Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Must be able to give voluntary written (patients may not be able to write) consent.
- Must be able to understand study information provided to him.
- CKD patients of stage IV and ESRD with age 18 to 65 years.
- Patient should be afebrile 24 hours prior to procedure.
Exclusion Criteria:
- Women who are pregnant or lactating
- Acute Renal Failure
- Severe co-morbidities like cardiac insufficiency, congestive cardiac failure, malignancy, infection, sepsis and bed sores.
- Haemoglobin level below 8g %
- Chronic kidney disease due to autoimmune aetiology, connective tissue disease, amyloidosis and storage disorders.
- Known bleeding or coagulation disorder.
- Known hematologic disease
- Poorly controlled hypertension
- Evidence of active malignancy within one year prior to randomization.
- Severe skin infection or osteomyelitis - the site of bone marrow aspiration potentially limiting the procedure.
- Have a known allergy to iodinated contrast
- Positive test results for HIV and AIDS complex, HCV, HbsAg and Syphilis.
- History of drug or alcohol abuse
- Patients on immunosuppressive therapy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Autologous bone marrow stem cells
|
Bone marrow stem cells; Single dose; Interventional fluoroscopy-guided injection into the renal artery.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Significant clinical improvement in serum creatinine and urine output (improvement in measured GFR by 50%)
Time Frame: 1 year
|
1 year
|
Number of patients reporting adverse effects as a measure of safety and tolerability
Time Frame: 1 year
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Improvement in renal biopsy
Time Frame: 1 year
|
1 year
|
Collaborators and Investigators
Investigators
- Study Director: Balakrishna S, M.B.B.S, International Stemcell Services Limited
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ISSL-AuBM-CRF
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Renal Failure
-
University of Sao Paulo General HospitalUnknownRenal Transplant Rejection | Graft Failure | Transplant; Failure, Kidney | Chronic Renal Failure (CRF)Brazil
-
Angiodynamics, Inc.TerminatedChronic Kidney Disease | Acute Kidney Injury | Acute Renal Failure | Renal Failure Chronic Contrast InducedUnited States
-
Rockwell Medical Technologies, Inc.CompletedRenal Failure Chronic Requiring HemodialysisUnited States, Puerto Rico
-
Rockwell Medical Technologies, Inc.CompletedRenal Failure Chronic Requiring HemodialysisUnited States, Canada
-
PfizerCompletedChronic Renal Failure Requiring HemodialysisUnited States, Puerto Rico
-
University of PennsylvaniaTeleflex; Arrow InternationalCompletedRenal Failure Chronic Requiring Hemodialysis | Chronic Renal InsufficiencyUnited States
-
Esraa Ahmed MohamedUnknownEvaluations of Sexual Dysfunction of Female in Chronic Renal Failure
-
Shenyang Sunshine Pharmaceutical Co., LTD.UnknownChronic Renal Failure With HemodialysisChina
-
PfizerCompletedChronic Renal Failure Requiring HemodialysisUnited States
-
Washington University School of MedicineCompletedAcute Renal Failure | Chronic Renal FailureUnited States
Clinical Trials on Autologous bone marrow stem cells
-
International Stemcell Services LimitedUnknownOsteoarthritisIndia
-
Assiut UniversityUnknownStem Cell Transplant Complications
-
Fundacion para la Formacion e Investigacion Sanitarias...Carlos III Health Institute; Hospital Universitario Virgen de la Arrixaca; Hospital... and other collaboratorsCompletedAmyotrophic Lateral SclerosisSpain
-
Hadassah Medical OrganizationCompletedMultiple Sclerosis
-
TCA Cellular TherapySuspendedAmyotrophic Lateral SclerosisUnited States
-
Al-Azhar UniversityHassan , Hosny , M.D. M.Sc; Samour , Hany M.D. M.Sc; Ismail , Mahmoud M.D. M.Sc; Higazy , Hasan M.D. M.Sc and other collaboratorsUnknownAge Related Macular DegenerationEgypt
-
Silesian School of MedicineMinistry of Science and Higher Education, PolandCompletedMyocardial InfarctionPoland
-
Nanjing PLA General HospitalUnknownImmune Function in Blood | Liver Function in Blood | Variation of Ascites | Characters of Quality of Life | Child-Pugh ScoreChina
-
Meshalkin Research Institute of Pathology of CirculationCompleted
-
Germans Trias i Pujol HospitalMinisterio de Sanidad, Servicios Sociales e IgualdadCompletedRelapsing Remitting Multiple Sclerosis (RRMS)Spain